Literature DB >> 15218265

Cloning and characterization of the murine Vmd2 RFP-TM gene family.

F Krämer1, H Stöhr, B H F Weber.   

Abstract

Mutations in the human vitelliform macular dystrophy type 2 (VMD2) gene are known to cause autosomal dominant Best macular dystrophy (BMD), a degenerative disorder of the central retina. VMD2, together with VMD2L1, VMD2L2 and VMD2L3, belong to a closely related gene family characterized by several transmembrane (TM) spanning helical domains and an invariant arginine, phenylalanine and proline (RFP) tripeptide motif, thus termed VMD2 RFP-TM. The four genes are thought to encode a novel family of anion channels. We now report the cloning and characterization of the murine orthologs by combining biocomputational analyses and molecular genetic approaches. While the murine Vmd2, Vmd2l1 and Vmd2l3 genes are functional, murine Vmd2l2p was found to be a non-transcribed pseudogene. Expression profiling of the murine Vmd2 RFP-TM family members revealed tissue-restricted expression with predominant transcription of Vmd2 in testis, of Vmd2l1 in colon and of Vmd2l3 in heart. Differential splicing was observed for Vmd2l3 in a number of tissues (e.g. in brain, retina/RPE, kidney) although the functional importance of the splice variants remains to be determined. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218265     DOI: 10.1159/000078016

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  29 in total

1.  Expression of three distinct families of calcium-activated chloride channel genes in the mouse dorsal root ganglion.

Authors:  Mohammed Al-Jumaily; Alexei Kozlenkov; Ilana Mechaly; Agnes Fichard; Valerie Matha; Frederique Scamps; Jean Valmier; Patrick Carroll
Journal:  Neurosci Bull       Date:  2007-09       Impact factor: 5.203

2.  Functional properties of murine bestrophin 1 channel.

Authors:  Kate E O'Driscoll; Normand Leblanc; William J Hatton; Fiona C Britton
Journal:  Biochem Biophys Res Commun       Date:  2009-05-06       Impact factor: 3.575

Review 3.  Bestrophin 1 and retinal disease.

Authors:  Adiv A Johnson; Karina E Guziewicz; C Justin Lee; Ravi C Kalathur; Jose S Pulido; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Prog Retin Eye Res       Date:  2017-01-30       Impact factor: 21.198

4.  A variant of the Ca2+-activated Cl channel Best3 is expressed in mouse exocrine glands.

Authors:  Alaka Srivastava; Victor G Romanenko; Mireya Gonzalez-Begne; Marcelo A Catalán; James E Melvin
Journal:  J Membr Biol       Date:  2008-03       Impact factor: 1.843

5.  Bestrophin-2 is a candidate calcium-activated chloride channel involved in olfactory transduction.

Authors:  Simone Pifferi; Giovanni Pascarella; Anna Boccaccio; Andrea Mazzatenta; Stefano Gustincich; Anna Menini; Silvia Zucchelli
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-15       Impact factor: 11.205

6.  Bestrophin-2 is involved in the generation of intraocular pressure.

Authors:  Benjamin Bakall; Precious McLaughlin; J Brett Stanton; Youwen Zhang; H Criss Hartzell; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

7.  Bestrophin 2 is expressed in human non-pigmented ciliary epithelium but not retinal pigment epithelium.

Authors:  Youwen Zhang; Rajkumar V Patil; Alan D Marmorstein
Journal:  Mol Vis       Date:  2010-02-10       Impact factor: 2.367

8.  A PI3 kinase inhibitor found to activate bestrophin 3.

Authors:  Zhiqiang Qu; Xiaohua Han; Yuanyuan Cui; Chunlin Li
Journal:  J Cardiovasc Pharmacol       Date:  2010-01       Impact factor: 3.105

9.  Stoichiometry and specific assembly of Best ion channels.

Authors:  Shashank Bharill; Zhu Fu; Raz Palty; Ehud Y Isacoff
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-18       Impact factor: 11.205

10.  Interleukin-10 overexpression promotes Fas-ligand-dependent chronic macrophage-mediated demyelinating polyneuropathy.

Authors:  Dru S Dace; Aslam A Khan; Jennifer L Stark; Jennifer Kelly; Anne H Cross; Rajendra S Apte
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.